Quantcast

Latest Glycosides Stories

80387e1f6946cb36f02a09b3f3c355651
2010-03-29 10:30:00

An all-natural, herbal artificial sweetener, approved for use in the U.S. in December 2008, has already earned a market share of $500 million, according to a March 28 AFP report. Rebaudioside A (Reb-A) and Purevia are two products made from a South American herb known as stevia, and have become attractive alternatives to aspartame and other sugar-replacing artificial sweeteners because it is all natural. According to Mintel, a global marketing research firm originally founded in the United...

2010-03-18 06:30:00

COLUMBIA, Md., March 18 /PRNewswire-FirstCall/ -- Celsion Corporation (Nasdaq: CLSN) today announced that an abstract about the Phase I/II trial of ThermoDox® in Recurrent Chest Wall Cancer (RCW) has been accepted for presentation at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting. The abstract presents the background, rationale, and design of the DIGNITY study which is ongoing and evaluating ThermoDox in combination with hyperthermia in women with...

2010-03-15 09:07:00

OAK BROOK, Ill., March 15 /PRNewswire/ -- PureCircle, the global leader in the production of high-purity stevia products, today announced that it's stevia-derived Reb A has so far helped customers eliminate a half-trillion calories from diets in the USA. The figure, based on product sales through the end of 2009, is indicative of stevia's potential to help policymakers, manufacturers and consumers address the nation's obesity epidemic. "In a matter of weeks, Michelle Obama's 'Let's Move'...

2010-02-22 06:00:00

SUGAR LAND, Texas and OAK BROOK, Ill., Feb. 22 /PRNewswire/ -- Imperial Sugar Company and PureCircle Limited are pleased to announce the launch of Natural Sweet Ventures LLC ("Natural Sweet"), a joint venture created between Imperial, one of the largest marketers of refined sugar in North America, and PureCircle, the global leader in the production of high purity stevia products. The exclusive North American joint venture will combine the natural benefits of both sugar and stevia to develop...

2010-02-10 06:30:00

COLUMBIA, Md., Feb. 10 /PRNewswire-FirstCall/ -- Celsion Corporation (Nasdaq: CLSN) announced today that after reviewing safety data from 120 patients enrolled in the pivotal Phase III ThermoDox® clinical trial ("HEAT" trial) for primary liver cancer, the Data Monitoring Committee (DMC) has recommended that Celsion continue to enroll patients in the trial. The DMC for the HEAT study is comprised of an independent group of medical and scientific experts who are...

2010-02-04 13:02:00

XI'AN, China, Feb. 4 /PRNewswire-Asia-FirstCall/ -- Huifeng Bio- Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, today announced preliminary 2009 results and provided guidance for 2010. Huifeng Bio-Pharmaceutical Technology anticipates revenues between $13 million to $14 million for the full year ended December 31, 2009. This...

2010-01-11 08:00:00

ASUNCION, Paraguay, Jan. 11 /PRNewswire/ -- On January 7th, PureCircle South America SA (PCSA) and the Cooperativa Colonias Unidas signed a contract for the production and supply of stevia leaves. The event was held at the Cooperative headquarters in Obligado and attended by managers and executives from both companies. Both PCSA and the Cooperative are forging a strong commitment to develop the production of proprietary varieties of high-quality stevia, to meet the growing international...

2010-01-07 06:00:00

PRINCETON, N.J., Jan. 7 /PRNewswire/ -- Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced today that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet(TM)) for first-line therapy of HER2 positive metastatic breast cancer. Treatment with Myocet(TM) has already shown a reduced level of cardiotoxicity as compared to...

2009-12-08 00:30:00

NEW ORLEANS, Dec. 8 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today an abstract to be published online at the journal Blood website by M. Hacker, et al. demonstrating significant reduction in cardiac cell toxicity with pixantrone compared to currently marketed anthracyclines. The authors conclude that the reduction is due to pixantrone's inability to generate toxic drug iron complexes and reduced propensity to generate oxygen free radicals....

739066839e06178e351155745429e3ec
2009-11-01 14:52:39

Going smaller could bring better results, especially when it comes to cancer-fighting drugs. Duke University bioengineers have developed a simple and inexpensive method for loading cancer drug payloads into nano-scale delivery vehicles and demonstrated in animal models that this new nanoformulation can eliminate tumors after a single treatment. After delivering the drug to the tumor, the delivery vehicle breaks down into harmless byproducts, markedly decreasing the toxicity for the...


Latest Glycosides Reference Libraries

45_20138aaa34c0aef5a2af87b137102229
2009-04-23 11:07:34

Bittercress (Barbarea vulgaris), also commonly known as Herb Barbara, Rocketcress, Yellow Rocketcress, Winter Rocket, and Wound Rocket, is a European biennial herb. This plant displays a rosette of shiny, dark green leaves at the base and additional pinnately divided leaves on the stem. In the spring, yellow flowers originate in tightly packed terminal groups just above the foliage. Bittercress grows wildly as a weed in many parts of North America. The flowers can be in bloom May...

More Articles (1 articles) »
Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related